Loading...
NPI 1073682035 · Oxford, MS · Urology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Doyle Renfroe is a urology physician provider located in Oxford, Mississippi. This profile covers 55 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Doyle Renfroe |
| Address | 1201 Medical Park Dr |
| City | Oxford |
| State | MS |
| ZIP | 38655 |
| Taxonomy | Urology Physician |
| NPI Enumerated | November 6, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.1M |
| Medicaid | $2.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
55 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 6,370 | $30 | $216.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 3,770 | $60 | $207.6K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 2,990 | $30 | $101.5K |
| 76770 | A retroperitoneal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e.Kidneys, urinary bladder, and aorta). This particular code is used when the ultrasound is… | 1,070 | $70 | $70.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 490 | $130 | $64.9K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 150 | $260 | $38.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 500 | $80 | $37.4K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 1,800 | $20 | $32.4K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 600 | $30 | $20.3K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 600 | $30 | $20.3K |
Showing 1–10 of 55
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 55 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
55 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 64590 | 1 | 20 | 30 | $6,100 | $201.4K |
| 87798 | 7 | 50 | 1,050 | $30 | $144.9K |
| 64561 | 3 | 20 | 40 | $2,180 | $141.6K |
| 87481 | 5 | 40 | 540 | $30 | $61.5K |
| J9217 | 3 | 50 | 170 | $130 | $30.4K |
| 99214 | 753 | 4,110 | 170 | $70 | $21.9K |
| 52000 | 19 | 70 | 90 | $130 | $18.3K |
| 52281 | 12 | 20 | 30 | $320 | $17.1K |
| 52353 | 6 | 10 | 10 | $920 | $15.7K |
| 50590 | 17 | 40 | 20 | $470 | $15.6K |
Showing 1–10 of 55
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 120 | $20 | $2.4K |
| 81003 | The lab analyst inserts a dip stick into a freshly collected urine specimen, removes the dipstick, and shakes off the excess urine. She places the stick onto a mechanical dip stick reader that will… | 100 | $1 | $100 |
How this provider's Medicaid billing volume and revenue compare to other Mississippi providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Mississippi median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,454 | 1,910 | 930 | $60 | $278.7K |
| 81003 | The lab analyst inserts a dip stick into a freshly collected urine specimen, removes the dipstick, and shakes off the excess urine. She places the stick onto a mechanical dip stick reader that will… | 216 | 300 | 440 | $1 | $3.3K |
Other providers in the same ZIP code as Doyle Renfroe, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.